Drs. Ben Solomon, Leora Horn, & Jack West evaluate the merits of broad genetic testing with a “next generation sequencing”…
Browsing: General
Drs. Ben Solomon, Leora Horn, & Jack West evaluate the evidence and consider whether there are clinically significant differences among…
Drs. Leora Horn, Ben Solomon, & Jack West review whether there are specific factors that should make one second generation…
Dr. Karen Reckamp of City of Hope Cancer Center reviews the concept of acquired resistance to targeted therapies in patients…
Xalkori (crizotinib) has had great success treating ALK positive lung cancer patients. The next generation of ALK inhibitors are also…
Xalkori (critzotinib) was the first approved treatment for ALK+ and ROS1 lung cancer. Since then, other drugs have been approved…
The brain is a common site of disease in patients with ALK+ lung cancer. In this video, Dr. Horn illustrates…
Janet Daily-Freeman moderates a question & answer session with Drs. Leora Horn and Taofeek Owonikoko on issues of acquired resistance…
There are sub-types within the sub-type of EGFR mutation positive lung cancer. In this presentation, Dr. Jack West discusses the…
Dr. Jack West suggests that progression in T790M-negative EGFR lung cancer patients may not require a change in therapy. In…
Drs. Jack West and Greg Riely field questions about which treatments should EGFR lung cancer patients consider when their cancers…
Brendan Bietry of the Patient Advocate Foundation discusses the financial assistance programs available to lung cancer patients who receive targeted…
Dr. Jack West, Brendan Bietry, and Janet Freeman-Daily take questions from the audience about financial assistance, legal protections, and patient…
Dr. Ed Kim from the Levine Cancer Institute in Charlotte, NC summarizes the mechanism of next generation sequencing (NGS), how…
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC discusses the feasibility of molecular marker testing and…
Dr. Jeffrey Bradley, Radiation Oncologist at Washington University in St. Louis, describes the use of stereotactic radiosurgery and stereotactic radiation…
Jamie Frediani, M.D. Board Certified Oncologist Who Provides Care For Pediatric Cancer Patients & Co-Director of AYA Program At CHOC…
Jamie Frediani, M.D. Board Certified Oncologist Who Provides Care For Pediatric Cancer Patients & Co-Director of AYA Program At CHOC…
Jamie Frediani, M.D. Board Certified Oncologist Who Provides Care For Pediatric Cancer Patients & Co-Director of AYA Program At CHOC…
Sen Zhuang, MD, PhD, VP, Oncology Clinical Research, Janssen, discusses Research & Development Philosophy At Janssen. At The 60th ASH…
Chadi Nabhan, MD, MBA, VP, Chief Medical Officer, Cardinal Health Specialty Solutions, discusses Skepticism Regarding MACRA. At The 60th ASH…
Chadi Nabhan, MD, MBA, VP, Chief Medical Officer, Cardinal Health Specialty Solutions, discusses Key Factors Contributing To Physician Burnout. At…
Chadi Nabhan, MD, MBA, VP, Chief Medical Officer, Cardinal Health Specialty Solutions, discusses The Role Of Advanced Practice Practitioners. At…
Chadi Nabhan, MD, MBA VP, Chief Medical Officer, Cardinal Health Specialty Solutions, discusses What Is Being Done To Prevent Oncologist…
Dr. Jack West summarizes his list of the top 5 most influential trials in lung cancer that reported results in…
In this video, Dharmisha Chauhan, MPharm, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the aims of her…
Healthcare technologies and apps are important in supporting patients in their care, and can greatly benefit them in their treatment…
Kelly Baillie, of the NHS Greater Glasgow & Clyde, Glasgow, UK, presents the key findings from the Cancer Medicines Outcome…
From the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK, Simon Cheesman, MRPharmS, from University College…
A specialist workshop on non-medical prescribing was hosted at the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, Birmingham, UK.…
The British Oncology Pharmacy Association (BOPA) has a number of exciting educational initiatives in the pipeline for 2019. BOPA committee…
Advanced therapy medicinal products (ATMPs) are a novel class of medicines offering treatment options for diseases that currently lack effective…
Substitutable Medical Apps, Reusable Technologies (SMART) apps have been developed to meet the need for responsiveness in healthcare IT. In…
Following the unfortunate IT failures at the Barts Health NHS Trust in 2017, which led to major issues in their…
Approved monoclonal antibodies for multiple myeloma (MM) are currently available, yet there are still gaps to explore in this therapeutic…
What is the current treatment landscape for plasma cell leukemia and extramedullary disease in multiple myeloma (MM)? We spoke to…
The results of clinical trials are open to interpretation and are dependent upon a vast array of factors, including cohort…
Here, Steven Pavletic, MD, MS, from the National Cancer Institute, Bethesda, MD, outlines areas of improvement for treating chronic graft-versus-host…
By understanding the pathogenesis of chronic graft-versus-host disease (GvHD), treatments can be better targeted to improve patient outcomes. In this…
Here, Steven Pavletic, MD, MS, from the National Cancer Institute, Bethesda, MD, discusses the previous management of chronic graft-versus-host disease…
Speaking from the 2018 European Group for Blood and Marrow Transplantation (EBMT) Annual Meeting, held in Lisbon, Portugal, Fermin Sanchez-Guijo,…
Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Abdul Hamid Bazarbachi,…
Here, Khaled Ghanem, MD, from the American University of Beirut, Beirut, Lebanon, outlines the collaborative approach taken by his institution,…
In this video, Khaled Ghanem, MD, from the American University of Beirut, Beirut, Lebanon, encourages the use of social media,…
Speaking from the 2018 European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting in Lisbon, Portugal, Khaled Ghanem, MD,…
From the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Patrick Kiel, PharmD, BCOP, BCPS, of Indiana…
In this video, Judith Smith, PharmD, BCOP, CPHQ, FCCP, FISOPP, of UTHealth McGovern Medical School, Houston, TX, delivers advice to…
In this video, Patrick Kiel, PharmD, BCOP, BCPS, of Indiana University Simon Cancer Center, Indianapolis, IN, describes how identifying molecular…
The importance of the clinical pharmacy specialist is often understated. Here, Judith Smith, PharmD, BCOP, CPHQ, FCCP, FISOPP, of UTHealth…